NCT02563080
- Conditions
- Acute Pancreatitis, Digestive System Diseases, Exocrine Pancreatic Insufficiency, +12 more
- Locations
-
- Helsinki University Hospital Helsinki, Finland
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,655 public trials
852 recruiting studies
Lymphoma trial results
NCT03527147
- Conditions
- DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Sarasota, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site New Orleans, Louisiana, United States
NCT03630159
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Emory University School of Medicine SC CTL019 Atlanta, Georgia, United States
- University of Chicago Medical Center Hematology and Oncology Chicago, Illinois, United States
- University of Kansas Hospital and Medical Center U of Kansas Cancer Center Kansas City, Kansas, United States
- Novartis Investigative Site Vienna, Austria
Completed
Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
NCT01516619
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Milan, Italy
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Highlands Oncology Group Springdale, Arkansas, United States
- The Regents of the University of California; Office of Research Irvine, California, United States
- Kootenai Cancer Center Post Falls, Idaho, United States
- Illinois Cancer Care, P.C. - Galesburg Galesburg, Illinois, United States
NCT01662050
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- A.O. Policlinico Consorziale Bari, BA, Italy
- IRCCS Ospedale Oncologico Bari, BA, Italy
- A.O. Spedali Civili Brescia, BS, Italy
- U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT Trani, BT, Italy
NCT01516593
- Conditions
- Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- Oncologia Medica A - Centro di Riferimento Oncologico Aviano (PN), Italy
- Ematologia - A.O. Spedali Civili Brescia, Italy
- Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Milan, Italy
- S.C. Oncologia Medica - Ospedale San Paolo Milan, Italy
NCT03536039
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ospedale San Raffaele Milan, Italy
Completed
Vinorelbine for Recurrent ACLC
NCT03397953
- Conditions
- Anaplastic Large Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Shanghai Children's Medical Center Shanghai, Shanghai Municipality, China
NCT03297424
- Conditions
- Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Honor Health Scottsdale, Arizona, United States
- Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
- Columbia University Medical Center New York, United States
- South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States